253 related articles for article (PubMed ID: 5978212)
1. The evolution of new drug legislation.
Kelsey FO
BMQ; 1966 Sep; 17(3):72-81. PubMed ID: 5978212
[No Abstract] [Full Text] [Related]
2. New drugs: the AMA and the FDA.
Appel JZ
Ann Allergy; 1966 Jul; 24(7):333-6. PubMed ID: 5941864
[No Abstract] [Full Text] [Related]
3. New drugs and the Kefauver-Harris amendment.
Krantz JC
J New Drugs; 1966; 6(2):77-9. PubMed ID: 5917906
[No Abstract] [Full Text] [Related]
4. Research regulation, and development of new pharmaceuticals: past, present, and future. 1.
Lasagna L
Am J Med Sci; 1972 Jan; 263(1):9-18. PubMed ID: 4257990
[No Abstract] [Full Text] [Related]
5. The dermatologist, the cosmetic chemist, and the new law.
Brauer EW
J Med Soc N J; 1965 Oct; 62(10):489-91. PubMed ID: 5213164
[No Abstract] [Full Text] [Related]
6. A backward step in drug control.
Feldman EG
J Pharm Sci; 1966 Sep; 55(9):i. PubMed ID: 5918545
[No Abstract] [Full Text] [Related]
7. One decade of food and drug law scholarship: a selected bibliography.
Noah L
Food Drug Law J; 2000; 55(4):641-58. PubMed ID: 12025854
[No Abstract] [Full Text] [Related]
8. Progress under the Kefauver-Harris Drug Amendments.
Rankin WB
Pharmakotherapia; 1964; 2(1):215-22. PubMed ID: 5875717
[No Abstract] [Full Text] [Related]
9. Toward more effective drug regulation.
Schmidt AM
FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532
[No Abstract] [Full Text] [Related]
10. RECENT EXPERIENCES WITH EFFECTIVE NEW DRUG APPLICATIONS.
MEYERS EL
Bull Parenter Drug Assoc; 1964; 18():1-6. PubMed ID: 14224959
[No Abstract] [Full Text] [Related]
11. Development of orphan products.
FDA Drug Bull; 1983 Apr; 13(1):2-4. PubMed ID: 6852406
[No Abstract] [Full Text] [Related]
12. Veterinary drug availability.
Gloyd J
J Am Vet Med Assoc; 1980 Apr; 176(7):611-4. PubMed ID: 7372533
[No Abstract] [Full Text] [Related]
13. Prescription drug advertising--should states regulate what is false and misleading?
Shaeffer J
Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
[No Abstract] [Full Text] [Related]
14. THE PHYSICIAN AND THE FOOD AND DRUG ADMINISTRATION.
SADUSK JF
JAMA; 1964 Dec; 190():907-9. PubMed ID: 14214493
[No Abstract] [Full Text] [Related]
15. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
16. The Drug Abuse Control Amendments of 1965.
R I Med J; 1966 Mar; 49(3):189 passim. PubMed ID: 5217555
[No Abstract] [Full Text] [Related]
17. Profitable and nonprofitable drugs.
Van Woert MH
N Engl J Med; 1978 Apr; 298(16):903-6. PubMed ID: 634333
[No Abstract] [Full Text] [Related]
18. Drugs of limited commercial value.
Van Woert MH
N Engl J Med; 1980 Jul; 303(2):114. PubMed ID: 7383068
[No Abstract] [Full Text] [Related]
19. Pharmaceutical postmarket review: fact or fiction?
Schanz SJ
Food Drug Law J; 2007; 62(3):493-500. PubMed ID: 17915391
[No Abstract] [Full Text] [Related]
20. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1984 Jun; 4(3):161-2. PubMed ID: 6096408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
